“…M2 activation, also known as alternatively activated, is induced by IL-4, IL-13, and IL-10 to secrete anti-inflammatory cytokines, such as IL-10 and transforming growth factor-β (TGF-β). They also release growth factors such as insulin-like growth factor-1 (IGF-1), colony-stimulating factor-1 (CSF-1), vascular endothelial growth factor (VEGF), and neurotrophins such as brain-derived neurotrophic factor (BDNF) and glial cell line-derived neurotrophic factor (GDNF), and their markers such as arginase-1 (Arg-1), chitinase-like protein 3 (also known as Ym1), cluster of differentiation (CD)163, and CD206, which are involved in tissue regeneration and repair, removal of cell debris, provision of trophic factors, and preservation of tissue dynamics following infection or damage [ 9 , 75 , 86 , 87 , 91 , 92 ]. The M2 phenotype can be further divided into three subclasses: M2a, M2b, and M2c [ 93 ].…”